Healios K.K. (OTCMKTS:HLOSF) Short Interest Up 2,083.3% in January

Healios K.K. (OTCMKTS:HLOSF) saw a significant growth in short interest in the month of January. As of January 31st, there was short interest totalling 13,100 shares, a growth of 2,083.3% from the January 15th total of 600 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.

Healios K.K. Price Performance

Healios K.K. stock remained flat at $0.96 during mid-day trading on Friday. The business has a 50 day moving average price of $1.12 and a two-hundred day moving average price of $1.34. Healios K.K. has a 1 year low of $0.93 and a 1 year high of $1.73.

Healios K.K. Company Profile

Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051 for treatment of ischemic stroke and acute respiratory distress syndrome; HLCN061 for treating solid tumors; HLCR011 for the treatment of retinal pigment epithelium tear and age-related macular degeneration; and HLCL041 for liver disease.